Related by context. All words. (Click for frequent words.) 67 doxepin HCl 66 SILENOR TM doxepin HCl 66 overactive bladder AA# 66 Empatic ™ 65 targeted radiotherapeutic 65 GABA aminotransferase inhibitor 65 Auxilium transmucosal film 65 CYT# vascular disrupting 64 hypoxia selective 64 IMPDH inhibitor 63 prokinetic agent 63 Hematide ™ peginesatide 63 AAG geldanamycin analog 63 Pimavanserin 63 Oral NKTR 62 SinuNase TM 62 combines bupropion 62 iSONEP ™ 62 Cannabinor 62 GSK# [002] 62 vi Immtech ability 62 2 methoxyestradiol 62 gepirone ER 62 sapropterin dihydrochloride Phase 62 NuMimetic TM 61 Dendreon investigational 61 ACAPODENE TM 61 midstage clinical 61 Anturol ® 61 include Phenoptin TM 61 ionotropic glutamate receptor antagonists 61 proprietary intravenous formulation 61 orally inhaled migraine 61 IMiDs ® 61 non porcine pancreatic 61 SinuNase ™ 61 ASONEP ™ 61 2A receptor agonist 61 Empatic TM 61 sulfonylhydrazine class 61 ocular formulation 60 muscarinic receptor agonist 60 polysaccharide polymer 60 TRIOLEX HE# APOPTONE HE# 60 PORxin TM 60 Vertex hepatitis C 60 Adenoscan R 60 Mg Uk 60 metaglidasen 60 Zemiva TM 60 anti amnesic 60 Corlux 60 NS5B polymerase 60 Personalized Immunotherapy 60 AFREZZA ® 60 Spiegelmer ® 60 sapacitabine CYC# 60 acute mania 60 Archexin 60 investigational pharmacologically unique 60 BiovaxID TM 60 CB2 selective receptor agonist 60 Ostabolin C TM 60 PF # [002] 60 delivery polymer matrix 60 molecular imaging radiopharmaceutical 60 PNP inhibitor 60 Synavive ™ 60 oral anti arrhythmic 60 psychiatric disorders ATI 59 MAGE A3 ASCI 59 pafuramidine maleate 59 intranasal formulation 59 candidates Azedra TM 59 gets USFDA nod 59 aerosolized AAT 59 intravenous acetaminophen 59 CYT# potent vascular disrupting 59 antidepressants fluoxetine 59 Safinamide 59 topically applied SEPA 59 commercialize deforolimus ARIAD 59 Initiates Clinical Trial 59 novel L DOS# 59 Zolpimist ™ 59 selective estrogen receptor modulator 59 oral prodrug 59 EVIZON TM squalamine lactate 59 Zeldox 59 Idera Pharmaceuticals develops 59 GLPG# 59 INSPIRE Trial Phase III 59 NB S# strontium malonate 59 bucindolol hydrochloride 59 investigational hepatitis C 59 Pegloticase 59 TBC# 59 lintuzumab SGN 59 Alzheimer disease cognitive dysfunction 59 commercialize CorMedix drug 59 neuro inflammatory 59 neuropathic pain spasticity 59 IMiDs R 59 thrombin component 59 AdhTAP 59 acetonide FA 59 KRN# 59 INxin 59 LymphoStat B TM 59 RhuDex ® 59 cortisol synthesis 59 depressive episodes associated 59 candidate deforolimus 59 urate lowering 58 delivers fluocinolone acetonide FA 58 Panzem R 58 treat chronic sinusitis 58 clinical trials Archexin 58 Silodosin 58 virus HCV protease inhibitor 58 PDX pralatrexate 58 Maribavir 58 Completes Patient Enrollment 58 etanercept Enbrel 58 faropenem medoxomil 58 Initiates Enrollment 58 OXIGON TM 58 non constipating irritable 58 phase III isavuconazole 58 rhIGF-I/rhIGFBP-3 58 opioid naive 58 D aspartate NMDA receptor 58 proprietary HuCNS SC 58 hypoxia activated prodrug 58 LymphoStat B belimumab 58 sores onychomycosis nail 58 ONCONASE R 58 candidate TNFerade biologic 58 M# rationally 58 OvaRex R 58 topically administered 58 aldehyde dehydrogenase ALDH2 deficiency 58 acyclovir Lauriad R 58 anti botulism antibody 58 THR beta agonist 58 PrevOnco ™ 58 Mg Usa 58 topical gel formulation 58 lorvotuzumab mertansine 58 Launches Generic Version 58 barbiturates benzodiazepines 58 mitoxantrone plus 58 Alfacell proprietary ribonuclease 58 cannabinor 58 injectable investigational 58 Anavex #-# 58 trial evaluating PRX# 58 humanized therapeutic 58 XL# anticancer compounds 58 candidate Zemiva TM 58 Acetavance TM intravenous acetaminophen 57 TRO# 57 ALTROPANE R 57 novel oral anticoagulant 57 candidate XP# 57 anti inflammatory NSAID 57 TOCOSOL Camptothecin 57 lysosomal storage disorder 57 EOquin TM phase 57 Annamycin 57 fusion enhancers 57 candidate REP# 57 beta 1a 57 clonidine hydrochloride 57 S1P antibody 57 Generx ™ 57 non nucleoside HCV 57 recombinant PSMA vaccine 57 SinuNase TM novel 57 refractory chronic lymphocytic 57 non nucleoside inhibitor 57 novel emulsion formulation 57 novel VDA molecule 57 MTP inhibitor 57 deCODE AF TM 57 Panzem ® 57 Tykerb lapatinib 57 refractory indolent non 57 kidney urologic 57 ALN PCS 57 HepDirect R 57 muscarinic receptor agonists 57 commercializing oxidized glutathione 57 R#/MEM # 57 Lexapro Effexor Serzone 57 omacetaxine mepesuccinate 57 Novolimus 57 rxRNA 57 thetreatment 57 Dementia Related Psychosis 57 Crofelemer budesonide foam 57 SILENOR 57 candidate Liposomal Grb 57 ropinirole Requip 57 PORxin TM platforms 57 targets Galectin receptors 57 metastatic carcinoid 57 oxycodone acetaminophen 57 rifalazil 57 ARIKACE ™ 57 use transdermal sumatriptan 57 Onconase 57 soft tabs levitra 57 CNS depressant 57 Intermezzo ® zolpidem tartrate 57 oxypurinol 57 Vidaza ® 57 Soliris TM eculizumab 57 cystic fibrosis bronchiectasis inhalation 57 REG2 Regado 57 Hsp# Inhibitor 57 maturation inhibition 57 Duromist ™ 57 Qutenza TM 57 Panzem R NCD 57 Amgen Neulasta ® 57 induced mucositis 57 JAK inhibitor 57 AKT inhibitor 57 highly selective inhibitor 57 Prodarsan R 57 molecular chaperone regulator 57 relapsed leukemia 57 oropharyngeal candidiasis OPC 57 Diabetic Macular Edema DME 57 TRIOLEX ™ 57 Teriflunomide 57 avanafil PDE5 inhibitor 57 potent suppressor 57 Initiate Clinical Trial 57 non cirrhotic portal 57 Optiquel ™ 57 central precocious puberty 56 SPRYCEL ® 56 PDE4 inhibitor 56 topical non steroidal 56 personalized immunotherapy 56 triggers apoptosis programmed 56 RH1 targeted chemotherapeutic agent 56 PrevOnco 56 Opterone R 56 ViaDerm hPTH #-# 56 Mesafem 56 Augment TM 56 Pagoclone 56 OncoVex 56 ASONEP TM 56 PPAR gamma agonist 56 Exelixis compounds 56 Vitrasert R 56 OMP #M# 56 demonstrated antitumor activity 56 rheumatoid arthritis inflammatory bowel 56 preclinical studies Vion 56 IMA# 56 pioglitazone hydrochloride 56 Linjeta TM 56 5 HT2A inverse 56 XOMA 3AB biodefense 56 using VIAdel TM 56 cladribine Cladribine Tablets 56 progressive metastatic prostate 56 Zoraxel 56 iSONEP TM 56 vascular occlusive diseases 56 EVIZON ™ 56 chemokine receptor CCR1 56 relapsed MM 56 oral nucleoside analogue 56 MAb therapy 56 GRNOPC1 contains 56 incyclinide 56 TRIOLEX HE# 56 Meets Primary Endpoint 56 mertansine 56 carcinoid syndrome diabetes 56 Sudhir Agrawal D.Phil 56 includes TOLAMBA TM 56 oxybutynin ATD TM 56 pralatrexate injection folate analogue 56 infectious diseases autoimmune 56 GERD migraine headaches 56 FOLFOX6 chemotherapy regimen 56 Aganocide 56 skeletal sarcomere activator 56 Sphingomab TM 56 pipeline GlycoPEG GCSF 56 generation purine nucleoside 56 treats acute lymphoblastic 56 oral beclomethasone dipropionate 56 interferon alpha IFN 56 sitaxsentan 56 naloxol derivative 56 Achieves Primary Endpoint 56 Alzheimer disease cognitive impairment 56 MCSP respectively 56 RTP #i 56 Factor VIIa 56 torsemide ER 56 Naive Patients 56 lead molecular radiotherapeutic 56 alvespimycin 56 immunotherapeutic approaches 56 solid tumors ZYBRESTAT 56 mild vasodilator 56 histamine dihydrochloride 56 sorafenib tablets 56 inhibit platelet function 56 Tolevamer 56 TELINTRA R 56 PLX STROKE targeting 56 hypertension osteoarthritis 56 inhibitor COX 56 refractory gout 56 TG# [003] 56 successfully commercialize Iluvien 56 Perflubutane Polymer Microspheres 56 investigational humanized monoclonal antibody 56 Temsirolimus 56 allosteric modulator PAM 56 Paliperidone ER 56 Solazed TM 56 SYN# 56 Prozac Paxil Zoloft Celexa 56 sterile lidocaine patch 56 migraine headaches neuropathic pain 56 ® lenalidomide 56 Phase IIb clinical trials 56 antihormonal 56 MKC# 56 diabetes irritable bowel 56 syndrome gastroesophageal reflux 56 initiate Phase IIa 56 Receives Orphan Drug Designation 56 investigating Serdaxin 56 PANVAC VF 56 PDE# inhibitors 56 sublingual tablet formulation 56 lamotrigine Lamictal 56 HCV protease inhibitors 56 Solzira ™ 56 drug GAP #B# 56 PI3K/Akt pathway inhibitor 56 banned Darvon Darvocet 56 intravenous RSD# 56 either acutely decompensated 56 tolevamer 56 GW# [003] 56 proprietary Isolagen Process 56 Daclizumab 56 rheumatoid arthritis osteoarthritis ankylosing 56 PresbyLens ® 56 alpha1 antitrypsin deficiency 56 Elestrin ® 56 drug NP2 Enkephalin 56 including eniluracil ADH 56 itraconazole Sporanox 56 dasatinib Sprycel ® 55 psoriasis rheumatoid arthritis 55 BCG refractory carcinoma 55 Prednisone Against Refractory 55 HQK 55 Fx #A 55 peripherally acting 55 treat nephropathic cystinosis 55 liposomal formulation 55 PDE inhibitors 55 Files IND 55 deCODE ProstateCancer TM 55 commercializes VIVITROL ® 55 Presently DARA 55 PD2i CA Cardiac Analyzer 55 Submits Response 55 Initiates Phase II 55 Chantix Champix 55 prescribed proton pump 55 OvaRex 55 HP Acthar R 55 IV APAP 55 LEVADEX ™ 55 hereditary emphysema 55 compound perifosine 55 MKC# MT 55 investigational integrase inhibitor 55 tiapamil 55 next generation URAT1 55 Maxy G# 55 endothelin antagonist 55 Xcytrin R 55 Shows Promise Against 55 related CMV Retinitis 55 Associated Adipose Redistribution 55 investigational atypical antipsychotic 55 Panzem NCD 55 TLK# 55 multitargeted 55 JAK2 Inhibitor 55 Aflibercept 55 FUSILEV enhances 55 cromolyn sodium 55 vaccine GMK 55 constipation predominant irritable bowel 55 Bucindolol 55 Panzem 55 NeuroSTAT ® 55 accumulate preferentially 55 brand ciclesonide HFA 55 TPI ASM8 55 tolerability pharmacokinetics 55 orally administered inhibitor 55 neuropathic pain metabolic diseases 55 RhuDex R 55 mitogen activated ERK kinase 55 Trofex TM 55 pharmacodynamic effects 55 Solazed 55 DITPA 55 HEPLISAV ™ 55 MGd 55 Iloperidone 55 vapreotide acetate 55 methylnaltrexone bromide 55 triglyceride lowering 55 generation PNP inhibitor 55 therapeutic monoclonal antibody 55 GEM OS2 55 Xeloda ® 55 vaginal candidiasis 55 CYP#A# CYP#D# 55 Shigatoxin producing E. coli 55 Phase #b/#a clinical 55 Cloretazine 55 Mipomersen 55 basal insulin analogue 55 Marqibo TM 55 proprietary intranasal insulin 55 intranasal insulin product 55 inflammatory cardio metabolic 55 Cariprazine 55 FOLOTYN ® 55 CIMZIA r certolizumab pegol 55 AFREZZA TM 55 AQD class 55 NU# direct 55 TRIOLEX TM HE# 55 NP2 Enkephalin 55 adrenergic regulation 55 TOCOSOL R 55 PDE4 modulators 55 Vidaza azacitidine 55 IV Busulfex 55 Initiates Phase III 55 treat chronic rhinosinusitis 55 dermaceutical 55 BEMA Granisetron 55 orally disintegrating 55 inhaled TPI ASM8 55 Zybrestat 55 Iluvien ® 55 commercializes implantable 55 Amgen Neulasta R 55 thalidomide Thalomid 55 aurora kinase 55 Plaquenil 55 toenail onychomycosis 55 Genz # 55 XP# XP# 55 superparamagnetic iron oxide nanoparticles 55 NASH Huntington 55 INS# [001] 55 active cellular immunotherapy 55 candidate iSONEP TM 55 cardiotoxic 55 Zalypsis 55 inhaled liposomal ciprofloxacin 55 Posiphen TM 55 negative allosteric modulator 55 p# MAP kinase inhibitor 55 Glypromate 55 ZYBRESTAT fosbretabulin 55 Pfizer Camptosar 55 Azedra TM 55 ILUVIEN ® 55 Intravitreal 55 carbohydrate polymer 54 Submits NDA 54 Kosan dependence 54 PEGylated interferon 54 Simulect 54 treat secondary hyperparathyroidism 54 5 HT2A serotonin 54 morphine fentanyl 54 HIV RDEA# 54 topical gel containing 54 Cathepsin S 54 Muraglitazar 54 delivers sumatriptan 54 Orally administered 54 doxepin hydrochloride 54 Peginterferon alfa 2b 54 candidate ridaforolimus 54 OHR/AVR# 54 opioid bowel dysfunction 54 reslizumab 54 CTAP# Injection 54 MSCRAMM ® 54 DOS# 54 rusalatide acetate 54 refractory metastatic 54 Submits Biologics License Application 54 E2F Decoy 54 DEB# 54 Investigational Oral 54 BLyS specific 54 Budesonide foam crofelemer 54 romidepsin novel 54 oncolytic virus therapies 54 Granted Orphan Drug 54 TransVax tm 54 sertraline Zoloft 54 systemic anaplastic large 54 candidate DB# 54 pan histone deacetylase 54 Anidulafungin 54 HCV RNA polymerase 54 radiation sensitizer 54 Aganocide ® 54 cyclophilin inhibitors 54 Serostim ® 54 Squalamine 54 bardoxolone methyl 54 Cytarabine 54 EGS# 54 antianxiety 54 Pruvel 54 candidate KRN# 54 infectious diseases autoimmune diseases 54 Nexavar sorafenib tablets 54 ATRA IV 54 Omacetaxine 54 Interferon beta 54 AzaSite ISV 54 vinorelbine tartrate 54 outlicensed 54 AVAPRO 54 Aricept donepezil 54 selective immunoproteasome inhibitor 54 sNDAs 54 lenalidomide Revlimid R 54 selective phosphodiesterase 54 OMNARIS HFA 54 TNF Tumor Necrosis Factor 54 Oxymorphone ER 54 humanised monoclonal antibody 54 Darusentan 54 damage cirrhosis liver 54 CA9 SCAN 54 small molecule chemotherapeutic 54 Aviptadil 54 drugs cough suppressant 54 Memryte 54 dextromethorphan quinidine 54 Investigational Treatment 54 diarrhea predominant irritable 54 oral talactoferrin 54 Transdermal Patch 54 Trofex ™ 54 MKC# MKC# PP 54 Prednisporin TM 54 receptor tyrosine kinase inhibitor 54 nilotinib Tasigna ® 54 HepeX B TM 54 alkylating agent 54 CB2 selective 54 candidate custirsen 54 Anturol TM 54 Q#IR 54 Friedreich Ataxia FRDA 54 Aggrastat ® tirofiban hydrochloride 54 highly selective endothelin 54 treat hyperphosphatemia 54 erlotinib Tarceva ® 54 Drug Candidate 54 Naproxen sodium 54 histone deacetylase HDAC inhibitor 54 ATPace TM 54 Angiocept 54 Phase #b/#a trial 54 mGluR5 PAM 54 XP #L 54 candidate Zemiva 54 chronic progressive neurodegenerative 54 Selective Serotonin Reuptake Inhibitors 54 hoFH 54 isavuconazole 54 EndoTAGTM 1 54 valtorcitabine 54 immunosuppressant therapies 54 Generx TM 54 Risperdal Zyprexa 54 neuroactive 54 antidepressant bupropion 53 ® bortezomib 53 Selective Serotonin Reuptake Inhibitor 53 Cancidas 53 systemically administered 53 TLR9 agonist IMO 53 cognitive impairment associated 53 therapeutic radiopharmaceuticals 53 memantine HCl 53 R Saizen R 53 alemtuzumab MS 53 Antiangiogenic 53 neuronal nicotinic receptor NNR 53 small molecule Hedgehog 53 reversible inhibitor 53 Cardio Vascu Grow 53 Nektar proprietary 53 SURFAXIN r 53 TRAIL receptor antibody 53 RhuDex TM 53 efaproxiral 53 neuroprotective properties 53 formerly LymphoStat B 53 markets COLAZAL 53 MGN# 53 personalized dendritic 53 dopamine hypothesis 53 vinca alkaloid 53 Alexza Staccato 53 retinal vein occlusion induced 53 DNA methyltransferase inhibitors 53 Horizant ™ 53 apomorphine hydrochloride 53 preclinical pharmacology 53 Perceiva 53 Mellaril 53 sleep aids Restoril 53 Unit Dose Budesonide 53 ZOLINZA 53 PEGylated Fab fragment 53 Divigel R 53 concerning CombinatoRx 53 Elagolix 53 FM VP4 53 XL# XL# 53 multiple sclerosis fibromyalgia 53 vitro dissolution 53 RELOVAIR ™ 53 PROMETA Treatment Program 53 HEPLISAV TM hepatitis B 53 Bayer HealthCare Onyx Pharmaceuticals 53 3 registrational trial 53 Canvaxin TM 53 inhibit metastasis 53 Lixivaptan 53 tamoxifen citrate 53 Darapladib 53 Liprotamase 53 neuropathy sparing 53 LEP ETU 53 Kuvan TM sapropterin 53 ViroChem 53 Cholesterol lowering statins 53 sargramostim 53 Darinaparsin 53 neovascular wet age 53 lucinactant 53 Soriatane 53 cisplatin gemcitabine 53 opiates muscle relaxants 53 mGluR5 antagonists 53 Inhibiting Nitric Oxide Donating 53 serotonin reuptake inhibitors SSRIs 53 Veronate R 53 antimitotic 53 CORT # estimates 53 ALN TTR# 53 oral proteasome inhibitor 53 Aurora Kinase 53 Ception Therapeutics Inc. 53 HuMax 53 Zoraxel TM 53 BrachySil ™ 53 dutogliptin 53 TOCOSOL 53 psoriasis Crohn disease 53 5 FU leucovorin 53 Acapodene 53 substantially excreted 53 Pyridorin 53 Exalgo TM 53 AzaSite Plus 53 ADME properties 53 alemtuzumab Campath 53 Bevasiranib 53 Daiichi Sankyo Eli Lilly 53 EcoNail TM 53 polymer conjugate technology 53 cardio metabolic diseases 53 phase IIb III 53 Cintredekin Besudotox 53 EEG abnormalities 53 BN# [004] 53 manufactures RISPERDAL ® CONSTA 53 lorazepam Ativan 53 EVIZON TM 53 bronchiectasis cystic fibrosis 53 adenosine A2A 53 Interferon Beta 53 Myolimus 53 molecular imaging radiopharmaceuticals 53 ORE# 53 hyaluronidase enzyme 53 inflammatory autoimmune diseases 53 nanopharmaceutical 53 Augment ™ 53 OcuGene glaucoma genetic 53 HCV antiviral 53 fibrotic disorders 53 Letairis ambrisentan 53 epilepsy Parkinson disease 53 painkillers methadone Oxycontin 53 autoimmune uveitis 53 brivanib 53 solanezumab 53 antisense inhibitors 53 Allovectin 7 53 ergot derivatives 53 gastro intestinal inflammation 53 agonistic human 53 lexidronam injection 53 CTAP# 53 Begins Dosing 53 Bayer Onyx 53 PEG uricase 53 afamelanotide 53 efficacy tolerability 53 R sorafenib tablets 53 candidate AP# 53 Sodium oxybate 53 DURIN TM 53 ART# 53 Pafuramidine 53 candidates Azedra 53 naronapride 53 inhaled antibiotic 53 GPR# agonist 53 Romidepsin 53 dasatinib Sprycel 53 Intravitreal injections 53 OvaRex ® MAb 53 product candidate Lpathomab 53 polycythemia vera essential thrombocythemia 53 IL# PE#QQR 53 Trofex 53 Aceon 53 GlaxoSmithKline Plc Paxil 53 compound tesamorelin 53 midstage clinical trials 53 Angiotensin receptor blockers 53 Initiate Phase 53 dual orexin receptor 52 drug Treanda 52 Ribavirin causes 52 induced anemia 52 Methadone Xanax 52 Gemzar gemcitabine 52 proteasome inhibitor 52 PEGylated docetaxel 52 ATL# [002] 52 involuntary dyskinetic movements 52 Tezampanel 52 initiated Phase Ib 52 novel antifolate 52 pediatric Crohn disease 52 DPX Survivac 52 gallium nitrate 52 Cotara ® 52 Puricase PEG uricase 52 dyslipidemia hypertension diabetes 52 essential thrombocythemia ET 52 romazarit 52 Azmacort R 52 Drug memoriesUnderbelly star 52 Phase 1b clinical trials 52 Familial Adenomatous Polyposis FAP 52 Prosaptide 52 non resectable metastatic 52 neuronal nicotinic receptors NNRs 52 Novartis NVS Snapshot Report 52 Technosphere ® 52 tubulin inhibitor 52 BZL# 52 Akt inhibitor 52 Refractory Hodgkin Lymphoma 52 MetroGel 52 Deforolimus 52 MoxDuo TM IR 52 common neurovascular complication 52 Monogram Trofile Assay 52 ficlatuzumab 52 manufactures VIVITROL ® 52 constipation OIC 52 staphylococcal vaccine 52 Bezielle 52 STEDESA 52 rufinamide 52 ALVESCO R 52 morphine Vicodin 52 corticosteroid dexamethasone 52 phase IIb clinical 52 Bosutinib 52 schizophrenia bipolar mania 52 topical antifungal 52 inflammation autoimmune diseases 52 adecatumumab MT# 52 compound AEZS 52 Troxatyl 52 Tß4 52 elvucitabine 52 oral picoplatin 52 Presents Preclinical Data 52 Zorbtive TM 52 Ketotransdel 52 prescribed benzodiazepine 52 lymphomas leukemias 52 exocrine pancreatic insufficiency EPI 52 Presents Preclinical 52 initiate Phase IIb 52 donepezil Aricept 52 indolent follicular non 52 Initiates Clinical 52 Benlysta belimumab 52 hormone refractory metastatic prostate 52 MediGene focuses 52 drug GLPG# 52 volociximab 52 Genentech sanofi aventis 52 Civacir 52 demonstrated anti amnesic 52 neratinib 52 NNR Therapeutics 52 Wellbutrin bupropion 52 induced macular edema 52 teplizumab 52 immunomodulatory therapy 52 Almorexant 52 preclinically 52 indications Cytokinetics 52 Treatment Resistant 52 GVAX ® 52 5 FU capecitabine 52 Certified Payment Processing 52 bladder ovarian 52 Cimzia TM 52 Phase IIb III 52 Vascular Disrupting Agent 52 FDA Approves Novel 52 Initiates Dosing 52 chronic thromboembolic pulmonary 52 painkillers sedatives 52 inhalant addiction 52 TÎ ² 4 52 tezampanel 52 Non inferiority 52 Xanafide 52 Salagen 52 Inhalation Aerosol 52 isoform selective 52 using Innocoll proprietary 52 iobenguane 52 manufactures minimally invasive 52 AVI RNA based 52 postoperative ileus POI 52 dihydrochloride 52 BHT DNA 52 Campath ® 52 NS#/#A protease 52 anti PlGF 52 MAP# 52 oral dihydropyrimidine dehydrogenase DPD 52 tezampanel NGX# 52 Oral Spray 52 Inhaling asbestos fibers 52 favorable pharmacokinetic 52 serotonin reuptake inhibitors 52 treating psychiatric disorders 52 CRMD# 52 human Chorionic Gonadotropin 51 OSI Tarceva 51 Nexavar sorafenib 51 VitiGam TM 51 syndrome carcinoid syndrome 51 Novel Oral 51 Bioaccelerate compounds under 51 Ovitrelle R Serostim 51 random suspicionless employee 51 pharmacodynamic markers 51 PGL# 51 APR Labtec 51 USP Tablets PEPCID 51 histone deacetylase inhibitor 51 gastrointestinal stromal 51 Aryplase 51 Teagan intubated 51 RhuDex 51 Bisphosphonate 51 novel antiviral therapeutics 51 myopic macular degeneration 51 ospemifene 51 squalamine 51 Onalta ™ 51 used DNA alkylating 51 #HT# 51 TKB# 51 Rilonacept 51 Fibrillex TM 51 LAB CGRP 51 reformulates existing FDA 51 novel therapeutic antibodies 51 HSP# inhibitor 51 TELINTRA 51 Impax ANDA 51 OREXIGEN 51 fibrotic diseases 51 mycophenolic acid 51 using performance enchancing 51 Initiates Phase 2b 51 receiving opioid analgesics 51 molecular chaperone regulation 51 non hodgkin lymphoma 51 Zemiva ™ 51 COPEGUS R 51 Surfaxin LS 51 Monoclonal antibody 51 Licenses Novel 51 Hypertensive adverse reactions 51 ix Immtech ability 51 includes AstraZeneca Accolate 51 targeted nucleotide prodrug 51 Research www. elsevier.com 51 Myelodysplastic Syndrome MDS 51 integrative pharmacology 51 chemosensitizer 51 Occlusin TM 51 estrogen receptor modulators 51 Anti VEGF 51 Prochymal TM 51 Leukine ® 51 replaced Brent Mydland 51 novel immunotherapies 51 Pathway Inhibitor 51 anaphylactic reactions bronchospasm 51 #:#-#,# CrossRef Medline [001] 51 Janus kinase 51 Peyronie Disease 51 brazen Conn. 51 PEG irinotecan 51 convulsive disorders 51 Bazedoxifene 51 bardoxolone 51 REGEN trial 51 PRN FDA Approves 51 Tarvacin Anti Cancer 51 Eculizumab 51 R lenalidomide 51 BEMA ® 51 intravenous recombinant 51 huC# DM4 51 fludarabine phosphate 51 XmAb ™ 51 atherosclerosis rheumatoid arthritis 51 radiotherapeutic 51 optimal dosing regimens 51 multivalency 51 purinergic receptors P#X# 51 Retisert ® 51 IAP inhibitor 51 collagen vascular 51 epothilones 51 catheter occlusion 51 modified glutathione analog 51 treatmentof 51 octreotide implant 51 JAK3 inhibitor 51 pan HDAC inhibitor 51 Linjeta ™ 51 Anti depressant